Who is it suitable for
Other GLP-1s Support for all GLP-1 receptor agonists with customizable tracking for any dosing schedule
1 Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing, China, 2 The Second Affiliated Hospital of Xingtai Medical College, Xingtai, China, 3 Bishan Hospital of Chongqing Medical University, Chongqing, China, 4 Gan & Lee Pharmaceuticals, Beijing, China
Helps reduce the appearance of wrinkles and sun damage Reduces inflammation and oxidative stress
Monitoring parameters typically assessed in trials include: Body weight and BMI measured at each visit to track progress Blood glucose and HbA1c particularly important for participants with type 2 diabetes or non-diabetic hyperglycaemia (sometimes called prediabetes) Lipid profile including total cholesterol, LDL, HDL, and triglycerides Liver function tests given the metabolic effects of glucagon receptor activation Renal function especially relevant if gastrointestinal side effects lead to reduced fluid intake Blood pressure and heart rate cardiovascular parameters are routinely assessed Calcitonin levels some trial protocols include calcitonin measurement given the theoretical thyroid C-cell risk associated with GLP-1 receptor agonists, based on rodent data
You may see modest weight changes after taking it consistently for at least 8 weeks, together with a balanced diet and regular physical activity
